who are we?

Since 1993, Hammersmith Medicines Research (HMR) has supplied industry-leading services to pharmaceutical companies for phase I and early phase II clinical trials.  Today, we have 145 beds in a purpose-designed clinical pharmacology unit close to an NHS hospital. We can provide a full service, including pharmacy, from trial design through to report.

Our GMP-compliant, 200 m² pharmacy was purpose designed and commissioned in accordance with MHRA best practice, and incorporated into our ISO 9001 quality management system.  We manufacture non-sterile, sterile and radioactive IMPs, and have had an MIA (IMP) since 2004.

We:

• import IMPs and challenge agents from outside the EEA;
• collaborate with sponsors to develop, refine, and test small-scale production methods;
• prepare finished sterile and non-sterile products;
• prepare sterile and non-sterile radiopharmaceuticals;  
• repack, randomise and label IMPs and non-IMPs;
• manufacture and assemble hard-shell capsules;
• over-encapsulate other solid dose forms;
• QP release;
• dispense Controlled Drugs; and
• prepare dilutions of challenge agents, such as allergens and methacholine.

Our established pharmacy team includes 5 registered pharmacists, and 3 QPs.